Astera Labs, Inc. $ALAB Shares Sold by Oak Grove Capital LLC

Oak Grove Capital LLC cut its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 12.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 34,040 shares of the company’s stock after selling 5,010 shares during the quarter. Oak Grove Capital LLC’s holdings in Astera Labs were worth $12,117,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. GK Wealth Management LLC purchased a new stake in shares of Astera Labs during the 3rd quarter valued at approximately $29,000. Cadent Capital Advisors LLC purchased a new position in Astera Labs in the 3rd quarter valued at approximately $1,845,000. Farther Finance Advisors LLC raised its holdings in Astera Labs by 102.8% during the 3rd quarter. Farther Finance Advisors LLC now owns 6,043 shares of the company’s stock valued at $2,151,000 after acquiring an additional 3,063 shares during the period. CoreCap Advisors LLC raised its holdings in Astera Labs by 21.0% during the 3rd quarter. CoreCap Advisors LLC now owns 749 shares of the company’s stock valued at $267,000 after acquiring an additional 130 shares during the period. Finally, Cooper Financial Group purchased a new stake in shares of Astera Labs during the third quarter worth $203,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Price Performance

Shares of ALAB opened at $342.21 on Friday. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48. The company has a market capitalization of $59.37 billion, a P/E ratio of 169.41 and a beta of 3.68. The firm’s 50 day simple moving average is $317.44 and its 200 day simple moving average is $290.39.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The business had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. During the same quarter in the prior year, the firm earned $0.44 earnings per share. The firm’s revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities analysts anticipate that Astera Labs, Inc. will post 2.70 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Morgan Stanley lifted their price target on Astera Labs to $335.00 and gave the company an “overweight” rating in a research report on Monday, August 3rd. Northland Securities cut Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Friday. TD Cowen lowered their price target on shares of Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a report on Wednesday, August 5th. Weiss Ratings upgraded shares of Astera Labs from a “hold (c)” rating to a “buy (b-)” rating in a research report on Thursday. Finally, Susquehanna boosted their price objective on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research note on Friday, July 31st. Eleven analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $348.33.

Insider Buying and Selling at Astera Labs

In related news, Director Manuel Alba sold 183,000 shares of the stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the transaction, the director owned 253,863 shares of the company’s stock, valued at approximately $71,114,642.19. This trade represents a 41.89% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the company’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the sale, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at approximately $431,109,432.75. The trade was a 6.68% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders sold 408,558 shares of company stock valued at $127,306,034. 10.40% of the stock is currently owned by corporate insiders.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs introduced Aries 7, described as the industry’s first PCIe 7 signal-conditioning portfolio spanning copper and optical interconnects. The lineup includes retimers, redrivers, cable modules, optical drivers and optical transimpedance amplifiers, positioning the company to benefit from expanding AI infrastructure and higher-speed data-center connectivity. Astera Labs Announces Aries 7
• Positive Sentiment: Marvell’s projection that connecting AI chips could become a $37 billion business reinforced investor optimism about the broader AI-connectivity market and helped highlight Astera’s growth opportunity. However, the companies discussed in the coverage remain dependent on major customers. Marvell AI Connectivity Market Forecast
• Neutral Sentiment: Analysts and market coverage are comparing Astera’s role in connecting AI racks with Micron’s memory and system exposure. Astera offers substantial growth potential, but competition from Marvell and Credo is intensifying. Micron Versus Astera Labs
• Negative Sentiment: Northland Securities downgraded ALAB from “outperform” to “market perform,” adding pressure to the shares and signaling that the current valuation may already reflect substantial AI-related growth. Northland Securities Downgrade
• Negative Sentiment: Jim Cramer praised Astera’s business but criticized its price, reinforcing concerns that the stock’s valuation leaves limited room for execution mistakes or slower growth. Jim Cramer Discusses Astera Labs Valuation

Astera Labs Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.